Our Team

Jenene Thomas Communications, LLC is a dedicated biopharmaceutical advisory firm specializing in designing and executing fully integrated Investor Relations, Communications and Corporate Strategy programs to establish credibility and visibility for its clients.

With over 15 years of in-house, C-level biotech experience the company is committed to building concise, fundamental investor relations programs to deliver results. 

The company’s namesake and founder, along with her highly experienced team, guides the firm with her multi-national, pre-IPO, start-up, micro-cap/small-cap and turnaround IR/PR expertise and has lead numerous successful private and public financings, totaling over $450 million dollars.

Jenene Thomas Communications applies best practices with creativity and courage while leveraging a deep network of key life science decision makers to pursue its commitment of achieving each client’s mission and vision.

Our firm welcomes the opportunity to discuss and understand your needs to help build messaging platforms, develop momentum and drive value for your company.